Phase 1/2 trial of AXO-AAV-GM1 (AAV9-GLB1) gene therapy for infantile- and juvenile-onset GM1 gangliosidosis

被引：0

作者：

Tifft, Cynthia ^{[1
]}

D'Souza, Precilla ^{[1
]}

Johnston, Jean M. ^{[1
]}

Acosta, Maria T. ^{[1
]}

Nicoli, Elena-Raluca ^{[1
]}

Rothermel, Caroline ^{[1
]}

Thurm, Audrey ^{[2
]}

Karunakara, Ajith ^{[3
]}

Thorp, Benjamin ^{[3
]}

Ross, Peter ^{[3
]}

Jameson, John ^{[3
]}

Sheehan, Michael ^{[3
]}

Vaughn, Toby ^{[3
]}

Valencia, Donna ^{[3
]}

De Boever, Erika ^{[3
]}

Corcoran, Gavin ^{[3
]}

机构：

[1] Nat Human Genome Res Inst, Bethesda, MD USA

[2] Nat Inst Mental Hlth, Bethesda, MD USA

[3] Sio Gene Therapies Inc, New York, NY USA

来源：

MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2021.11.317

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

302

引用

页码：S119 / S119

页数：1

共 50 条

[1] A phase 1/2 trial of AXO-AAV-GM1 gene therapy for the treatment of infantile- and juvenile-onset GM1 gangliosidosis
Tift, Cynthia
D'Souza, Precilla
Johnston, Jean
Acosta, Maria
Nicoli, Elena-Raluca
Rothermel, Caroline
Thurm, Audrey
Karunakara, Ajith
Thorp, Benjamin
Ross, Peter
Jameson, John
Sheehan, Michael
Vaughn, Toby
Valencia, Donna
De Boever, Erika
GENETICS IN MEDICINE, 2022, 24 (03) : S164 - S164
[2] Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis
Tifft, C.
D'Souza, P.
Johnston, J. M.
Acosta, M. T.
Nicoli, E. R.
Rothermel, C.
Thurm, A.
Karunakara, A.
Thorp, B.
Ross, P.
Jameson, J.
Sheehan, M.
Vaughn, T.
Valencia, D.
De Boever, E.
Corcoran, G.
HUMAN GENE THERAPY, 2021, 32 (19-20) : A11 - A12
[3] Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis: Preliminary Results
Tifft, C.
D'souza, P.
Johnston, J.
Acosta, M.
Rothermel, C.
Thurm, A.
Karunakara, A.
Thorp, B.
Ross, P.
Jameson, J.
Vaughn, T.
Valencia, D.
De Boever, E.
Corcoran, G.
ANNALS OF NEUROLOGY, 2021, 90 : S98 - S98
[4] AXO-AAV-GM1 for the treatment of GM1 gangliosidosis: Program Overview
Corcoran, G.
Korner, P.
Benoit, J.
Tifft, C. J.
Gray-Edwards, H.
Sena-Esteves, M.
Martin, D. R.
HUMAN GENE THERAPY, 2019, 30 (11) : A148 - A149
[5] AXO-AAV-GM2 Gene Therapy for Infantile- and Juvenile-onset GM2 Gangliosidosis: Preliminary Results from an Ongoing Phase 1/2 Trial
Eichler, Florian
Flotte, Terence
Andonian, Haley
Cataltepe, Oguz
Artinian, Rebecca
Misko, Albert
Thorp, Benjamin
Jameson, John
Sheehan, Michael
Vaughn, Toby
Valencia, Donna
De Boever, Erika
MOLECULAR THERAPY, 2022, 30 (05) : 6 - 7
[6] Intravenous delivery of AAV9-GLB1 gene therapy for GM1 gangliosidosis: An interim analysis
D'Souza, Precilla
Johnston, Jean M.
Thurm, Audrey
Farmer, Cristan
Gross, Amanda L.
Acosta, Maria T.
Tifft, Cynthia
MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
[7] AXO-AAV-GM1 for the Treatment of GM1 Gangliosidosis: Preliminary Results from a Phase I-II Trial
Tifft, Cynthia J.
D'Souza, Precilla
Johnston, Jean
Acosta, Maria
Rothermel, Caroline
Thurm, Audrey
Karunakara, Ajith
Thorp, Benjamin
Ross, Peter
Jameson, John
Vaughn, Toby
Valencia, Donna
De Boever, Erika
Corcoran, Gavin
MOLECULAR THERAPY, 2021, 29 (04) : 83 - 84
[8] Immune Modulation Preceding AAV9-GLB1 Gene Therapy Preserves the Possibility for Re-Dosing in Children with GM1 Gangliosidosis
D'Souza, Precill
Coleman, Kirsten E.
Rothermel, Caroline E.
Corti, Manuela
Tifft, Cynthia J.
Byrne, Barry J.
MOLECULAR THERAPY, 2021, 29 (04) : 92 - 93
[9] Intravenous Delivery of AAV Gene Therapy in GM1 Gangliosidosis
Gross, Amanda L.
Gray-Edwards, Heather
Batista, Ana Rita
Maitland, Stacy
Sena-Esteves, Miguel
Martin, Douglas R.
MOLECULAR THERAPY, 2018, 26 (05) : 136 - 136
[10] Intravenous Delivery of AAV Gene Therapy in GM1 Gangliosidosis
Gross, Amanda L.
Gray-Edwards, Heather L.
Bebout, Cassie N.
Neilson, Kayly
Brunson, Brandon L.
Batista, Ana Rita
Maitland, Stacy
Sena-Esteves, Miguel
Martin, Douglas
MOLECULAR THERAPY, 2019, 27 (04) : 191 - 191

← 1 2 3 4 5 →